Cargando…

7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors

A series of 3H-1,2-benzoxathiepine 2,2-dioxides incorporating 7-acylamino moieties were obtained by an original procedure starting from 5-nitrosalicylaldehyde, which was treated with propenylsulfonyl chloride followed by Wittig reaction of the bis-olefin intermediate. The new derivatives, belonging...

Descripción completa

Detalles Bibliográficos
Autores principales: Pustenko, Aleksandrs, Nocentini, Alessio, Balašova, Anastasija, Krasavin, Mikhail, Žalubovskis, Raivis, Supuran, Claudiu T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048192/
https://www.ncbi.nlm.nih.gov/pubmed/32079427
http://dx.doi.org/10.1080/14756366.2020.1722658
_version_ 1783502258088968192
author Pustenko, Aleksandrs
Nocentini, Alessio
Balašova, Anastasija
Krasavin, Mikhail
Žalubovskis, Raivis
Supuran, Claudiu T.
author_facet Pustenko, Aleksandrs
Nocentini, Alessio
Balašova, Anastasija
Krasavin, Mikhail
Žalubovskis, Raivis
Supuran, Claudiu T.
author_sort Pustenko, Aleksandrs
collection PubMed
description A series of 3H-1,2-benzoxathiepine 2,2-dioxides incorporating 7-acylamino moieties were obtained by an original procedure starting from 5-nitrosalicylaldehyde, which was treated with propenylsulfonyl chloride followed by Wittig reaction of the bis-olefin intermediate. The new derivatives, belonging to the homosulfocoumarin chemotype, were assayed as inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). Four pharmacologically relevant human (h) isoforms were investigated, the cytosolic hCA I and II and the transmembrane, tumour-associated hCA IX and XII. No relevant inhibition of hCA I and II was observed, whereas some of the new derivatives were effective, low nanomolar hCA IX/XII inhibitors, making them of interest for investigations in situations in which the activity of these isoforms is overexpressed, such as hypoxic tumours, arthritis or cerebral ischaemia.
format Online
Article
Text
id pubmed-7048192
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-70481922020-03-10 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors Pustenko, Aleksandrs Nocentini, Alessio Balašova, Anastasija Krasavin, Mikhail Žalubovskis, Raivis Supuran, Claudiu T. J Enzyme Inhib Med Chem Research Paper A series of 3H-1,2-benzoxathiepine 2,2-dioxides incorporating 7-acylamino moieties were obtained by an original procedure starting from 5-nitrosalicylaldehyde, which was treated with propenylsulfonyl chloride followed by Wittig reaction of the bis-olefin intermediate. The new derivatives, belonging to the homosulfocoumarin chemotype, were assayed as inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). Four pharmacologically relevant human (h) isoforms were investigated, the cytosolic hCA I and II and the transmembrane, tumour-associated hCA IX and XII. No relevant inhibition of hCA I and II was observed, whereas some of the new derivatives were effective, low nanomolar hCA IX/XII inhibitors, making them of interest for investigations in situations in which the activity of these isoforms is overexpressed, such as hypoxic tumours, arthritis or cerebral ischaemia. Taylor & Francis 2020-02-21 /pmc/articles/PMC7048192/ /pubmed/32079427 http://dx.doi.org/10.1080/14756366.2020.1722658 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Pustenko, Aleksandrs
Nocentini, Alessio
Balašova, Anastasija
Krasavin, Mikhail
Žalubovskis, Raivis
Supuran, Claudiu T.
7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
title 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
title_full 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
title_fullStr 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
title_full_unstemmed 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
title_short 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
title_sort 7-acylamino-3h-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase ix and xii inhibitors
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048192/
https://www.ncbi.nlm.nih.gov/pubmed/32079427
http://dx.doi.org/10.1080/14756366.2020.1722658
work_keys_str_mv AT pustenkoaleksandrs 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors
AT nocentinialessio 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors
AT balasovaanastasija 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors
AT krasavinmikhail 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors
AT zalubovskisraivis 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors
AT supuranclaudiut 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors